Furthermore, SLC14A2, which was significantly higher in both BoAA and Caucasian tumours compared to Asian cases has been shown to be down-regulated in chemotherapy-resistant ovarian cancer cell lines [28], suggesting potential race-specific targets for treatment. The gene discussed is SLC14A2; the disease is ovarian carcinoma.